A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)Central MessagePerspective

A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)Central MessagePerspective

Objective: To evaluate efficacy of S-1 (tegafur/gimeracil/oteracil), an active novel fluoropyrimidine, as compared to UFT (tegafur/uracil) as a postoperative adjuvant therapy in patients with node-negative non–small cell lung cancer (NSCLC). Methods: Eligible patients had undergone complete resectio...

Full description

Bibliographic Details
Main Authors: Hideo Kunitoh, MD, Masahiro Tsuboi, MD, Masashi Wakabayashi, MSc, Morihito Okada, MD, Kenji Suzuki, MD, Shun-ichi Watanabe, MD, Hisao Asamura, MD, H. Fukuda, T. Shibata, T. Kazato, T. Mizutani, J. Eba
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:JTCVS Open
Subjects:
non–small cell lung cancer
node-negative
adjuvant chemotherapy
tegafur/uracil
tegafur/gimeracil/oteracil
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273620300826

Similar Items

Similar Items